“A Sensitive Bioanalytical Method Development and Validation of Cabozantinib in Human Plasma by LC-ESI-MS MS”. Brazilian Journal of Pharmaceutical Sciences, vol. 54, no. 2, July 2018, p. e17163, https://doi.org/10.1590/s2175-97902018000217163.